ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Retrospective 1-Year Outcome Follow-Up in 200 Patients Supported With HeartMate 3 and HeartWare Left Ventricular Assist Devices in a Single Center

Friday, June 26, 2020

Submitted by

Emily Robinson

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Source URL: https://doi.org/10.1093/ejcts/ezaa017

Author(s)

Marcus Mueller, Christoph Hoermandinger, Gregor Richter, Johanna Mulzer, Dmytro Tsyganenko, Thomas Krabatsch, Christoph Starck, Julia Stein, Felix Schoenrath, Volkmar Falk, Evgenij Potapov

This original article retrospectively analyzed the outcome of 200 patients after implantation of HeartMate 3 and HeartWare LVAD respectively. The baseline characteristics of both groups, containing 100 patients each, were comparable, despite a higher percentage of INTERMACS I and II patients implanted with the HeartWare device. While the overall survival was not different, patients receiving HeartWare LVAD had more intracranial bleeding, while the total fraction of patients with cerebrovascular accidents was not different. The authors conclude that the devices show a different complication profile, but comparable intermediate survival.